Epstein-Barr virus (EBV). IV. Studies on experimental inactivated vaccine against human EBV infection.
It is well established that EBV-immunogen successfully invoke a strong neutralizing anti-EBV response in experimental animals. The authors report here the successful production of an EBV-immunogen prepared with whole disrupted productive cells of 2 MEBV cell line and with whole virus inactivated with ethylenimine (EI) which produce neutralizing anti-EBV response in experimental animals (calves, sheep, rabbits and SPF chickens).